Literature DB >> 21490218

The Down syndrome critical region regulates retinogeniculate refinement.

Martina Blank1, Peter G Fuerst, Beth Stevens, Navid Nouri, Lowry Kirkby, Deepti Warrier, Ben A Barres, Marla B Feller, Andrew D Huberman, Robert W Burgess, Craig C Garner.   

Abstract

Down syndrome (DS) is a developmental disorder caused by a third chromosome 21 in humans (Trisomy 21), leading to neurological deficits and cognitive impairment. Studies in mouse models of DS suggest that cognitive deficits in the adult are associated with deficits in synaptic learning and memory mechanisms, but it is unclear whether alterations in the early wiring and refinement of neuronal circuits contribute to these deficits. Here, we show that early developmental refinement of visual circuits is perturbed in mouse models of Down syndrome. Specifically, we find excessive eye-specific segregation of retinal axons in the dorsal lateral geniculate nucleus. Indeed, the degree of refinement scales with defects in the "Down syndrome critical region" (DSCR) in a dose-dependent manner. We further identify Dscam (Down syndrome cell adhesion molecule), a gene within the DSCR, as a regulator of eye-specific segregation of retinogeniculate projections. Although Dscam is not the sole gene in the DSCR contributing to enhanced refinement in trisomy, Dscam dosage clearly regulates cell spacing and dendritic fasciculation in a specific class of retinal ganglion cells. Thus, altered developmental refinement of visual circuits that occurs before sensory experience is likely to contribute to visual impairment in individuals with Down syndrome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21490218      PMCID: PMC3230532          DOI: 10.1523/JNEUROSCI.6015-10.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  82 in total

1.  High frequency, synchronized bursting drives eye-specific segregation of retinogeniculate projections.

Authors:  Christine L Torborg; Kristi A Hansen; Marla B Feller
Journal:  Nat Neurosci       Date:  2004-12-19       Impact factor: 24.884

Review 2.  Spontaneous patterned retinal activity and the refinement of retinal projections.

Authors:  Christine L Torborg; Marla B Feller
Journal:  Prog Neurobiol       Date:  2005-11-08       Impact factor: 11.685

3.  Synaptic structural abnormalities in the Ts65Dn mouse model of Down Syndrome.

Authors:  Pavel V Belichenko; Eliezer Masliah; Alexander M Kleschevnikov; Angela J Villar; Charles J Epstein; Ahmad Salehi; William C Mobley
Journal:  J Comp Neurol       Date:  2004-12-13       Impact factor: 3.215

4.  Ephrin-As and neural activity are required for eye-specific patterning during retinogeniculate mapping.

Authors:  Cory Pfeiffenberger; Tyler Cutforth; Georgia Woods; Jena Yamada; René C Rentería; David R Copenhagen; John G Flanagan; David A Feldheim
Journal:  Nat Neurosci       Date:  2005-07-17       Impact factor: 24.884

Review 5.  Molecular gradients and development of retinotopic maps.

Authors:  Todd McLaughlin; Dennis D M O'Leary
Journal:  Annu Rev Neurosci       Date:  2005       Impact factor: 12.449

6.  Ephrin-As mediate targeting of eye-specific projections to the lateral geniculate nucleus.

Authors:  Andrew D Huberman; Karl D Murray; David K Warland; David A Feldheim; Barbara Chapman
Journal:  Nat Neurosci       Date:  2005-07-17       Impact factor: 24.884

7.  Melanopsin-dependent photoreception provides earliest light detection in the mammalian retina.

Authors:  S Sekaran; D Lupi; S L Jones; C J Sheely; S Hattar; K-W Yau; R J Lucas; R G Foster; M W Hankins
Journal:  Curr Biol       Date:  2005-06-21       Impact factor: 10.834

8.  Competition in retinogeniculate patterning driven by spontaneous activity.

Authors:  A A Penn; P A Riquelme; M B Feller; C J Shatz
Journal:  Science       Date:  1998-03-27       Impact factor: 47.728

9.  Abnormal synaptic plasticity in the Ts1Cje segmental trisomy 16 mouse model of Down syndrome.

Authors:  Richard J Siarey; Angela J Villar; Charles J Epstein; Zygmunt Galdzicki
Journal:  Neuropharmacology       Date:  2005-07       Impact factor: 5.250

10.  Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: a model of Down syndrome.

Authors:  Alberto C S Costa; Michael J Grybko
Journal:  Neurosci Lett       Date:  2005-04-12       Impact factor: 3.046

View more
  27 in total

1.  Cell autonomy of DSCAM function in retinal development.

Authors:  Peter G Fuerst; Freyja Bruce; Ryan P Rounds; Lynda Erskine; Robert W Burgess
Journal:  Dev Biol       Date:  2011-10-29       Impact factor: 3.582

Review 2.  Advances in understanding the association between Down syndrome and Hirschsprung disease (DS-HSCR).

Authors:  S W Moore
Journal:  Pediatr Surg Int       Date:  2018-09-14       Impact factor: 1.827

3.  Role of DSCAM in the development of the spinal locomotor and sensorimotor circuits.

Authors:  Louise Thiry; Maxime Lemieux; Olivier D Laflamme; Frédéric Bretzner
Journal:  J Neurophysiol       Date:  2015-12-09       Impact factor: 2.714

4.  Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation.

Authors:  Sonja M Sachse; Sam Lievens; Luís F Ribeiro; Dan Dascenco; Delphine Masschaele; Katrien Horré; Anke Misbaer; Nele Vanderroost; Anne Sophie De Smet; Evgenia Salta; Maria-Luise Erfurth; Yoshiaki Kise; Siegfried Nebel; Wouter Van Delm; Stéphane Plaisance; Jan Tavernier; Bart De Strooper; Joris De Wit; Dietmar Schmucker
Journal:  EMBO J       Date:  2019-02-11       Impact factor: 11.598

5.  DSCAM promotes refinement in the mouse retina through cell death and restriction of exploring dendrites.

Authors:  Shuai Li; Joshua M Sukeena; Aaron B Simmons; Ethan J Hansen; Renee E Nuhn; Ivy S Samuels; Peter G Fuerst
Journal:  J Neurosci       Date:  2015-04-08       Impact factor: 6.167

6.  Neuronal clustering and fasciculation phenotype in Dscam- and Bax-deficient mouse retinas.

Authors:  Patrick W Keeley; Buranee J Sliff; Sammy C S Lee; Peter G Fuerst; Robert W Burgess; Stephen J Eglen; Benjamin E Reese
Journal:  J Comp Neurol       Date:  2012-05-01       Impact factor: 3.215

7.  DSCAM promotes axon fasciculation and growth in the developing optic pathway.

Authors:  Freyja M Bruce; Samantha Brown; Jonathan N Smith; Peter G Fuerst; Lynda Erskine
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-30       Impact factor: 11.205

8.  Novel axon projection after stress and degeneration in the Dscam mutant retina.

Authors:  K A Fernandes; S J Bloomsburg; C J Miller; S A Billingslea; M M Merrill; R W Burgess; R T Libby; P G Fuerst
Journal:  Mol Cell Neurosci       Date:  2015-12-10       Impact factor: 4.314

9.  Short-term treatment with the GABAA receptor antagonist pentylenetetrazole produces a sustained pro-cognitive benefit in a mouse model of Down's syndrome.

Authors:  D Colas; B Chuluun; D Warrier; M Blank; D Z Wetmore; P Buckmaster; C C Garner; H C Heller
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

10.  DSCAM-mediated control of dendritic and axonal arbor outgrowth enforces tiling and inhibits synaptic plasticity.

Authors:  Aaron B Simmons; Samuel J Bloomsburg; Joshua M Sukeena; Calvin J Miller; Yohaniz Ortega-Burgos; Bart G Borghuis; Peter G Fuerst
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.